Amgen, Entera ax $270M oral biologic pact 'out of mutual convenience'

Amgen has ended its alliance with Entera Bio. The partners entered into a $270 million, three-molecule deal in 2018 but have agreed to scuttle the collaboration before reaching any major milestones.